These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 10477545)

  • 1. The B-oligomer of pertussis toxin deactivates CC chemokine receptor 5 and blocks entry of M-tropic HIV-1 strains.
    Alfano M; Schmidtmayerova H; Amella CA; Pushkarsky T; Bukrinsky M
    J Exp Med; 1999 Sep; 190(5):597-605. PubMed ID: 10477545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The B-oligomer of pertussis toxin inhibits human immunodeficiency virus type 1 replication at multiple stages.
    Alfano M; Pushkarsky T; Poli G; Bukrinsky M
    J Virol; 2000 Sep; 74(18):8767-70. PubMed ID: 10954581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 gp120 and chemokine activation of Pyk2 and mitogen-activated protein kinases in primary macrophages mediated by calcium-dependent, pertussis toxin-insensitive chemokine receptor signaling.
    Del Corno M; Liu QH; Schols D; de Clercq E; Gessani S; Freedman BD; Collman RG
    Blood; 2001 Nov; 98(10):2909-16. PubMed ID: 11698270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monocyte chemoattractant protein-2 (CC chemokine ligand 8) inhibits replication of human immunodeficiency virus type 1 via CC chemokine receptor 5.
    Yang OO; Garcia-Zepeda EA; Walker BD; Luster AD
    J Infect Dis; 2002 Apr; 185(8):1174-8. PubMed ID: 11930329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolated human astrocytes are not susceptible to infection by M- and T-tropic HIV-1 strains despite functional expression of the chemokine receptors CCR5 and CXCR4.
    Boutet A; Salim H; Taoufik Y; Lledo PM; Vincent JD; Delfraissy JF; Tardieu M
    Glia; 2001 May; 34(3):165-77. PubMed ID: 11329179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited expression of R5-tropic HIV-1 in CCR5-positive type 1-polarized T cells explained by their ability to produce RANTES, MIP-1alpha, and MIP-1beta.
    Annunziato F; Galli G; Nappi F; Cosmi L; Manetti R; Maggi E; Ensoli B; Romagnani S
    Blood; 2000 Feb; 95(4):1167-74. PubMed ID: 10666186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interference with the signaling capacity of CC chemokine receptor 5 can compromise its role as an HIV-1 entry coreceptor in primary T lymphocytes.
    Wang JM; Oppenheim JJ
    J Exp Med; 1999 Sep; 190(5):591-5. PubMed ID: 10477544
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1.
    Xiang J; George SL; Wünschmann S; Chang Q; Klinzman D; Stapleton JT
    Lancet; 2004 Jun; 363(9426):2040-6. PubMed ID: 15207954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV co-receptors as targets for antiviral therapy.
    Schols D
    Curr Top Med Chem; 2004; 4(9):883-93. PubMed ID: 15134547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coreceptor competition for association with CD4 may change the susceptibility of human cells to infection with T-tropic and macrophagetropic isolates of human immunodeficiency virus type 1.
    Lee S; Lapham CK; Chen H; King L; Manischewitz J; Romantseva T; Mostowski H; Stantchev TS; Broder CC; Golding H
    J Virol; 2000 Jun; 74(11):5016-23. PubMed ID: 10799575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms involved in stimulation of human immunodeficiency virus type 1 replication by aminooxypentane RANTES.
    Marozsan AJ; Torre VS; Johnson M; Ball SC; Cross JV; Templeton DJ; Quiñones-Mateu ME; Offord RE; Arts EJ
    J Virol; 2001 Sep; 75(18):8624-38. PubMed ID: 11507208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. R5 HIV gp120-mediated cellular contacts induce the death of single CCR5-expressing CD4 T cells by a gp41-dependent mechanism.
    Blanco J; Barretina J; Clotet B; Esté JA
    J Leukoc Biol; 2004 Oct; 76(4):804-11. PubMed ID: 15258189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of dual/mixed tropic HIV-1 isolates by CCR5-inhibitors in primary lymphocytes and macrophages.
    Surdo M; Balestra E; Saccomandi P; Di Santo F; Montano M; Di Carlo D; Sarmati L; Aquaro S; Andreoni M; Svicher V; Perno CF; Ceccherini-Silberstein F
    PLoS One; 2013; 8(7):e68076. PubMed ID: 23874501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a post-entry barrier to R5 HIV-1 infection of CD4 memory T cells.
    Vyakarnam A; Eyeson J; Teo I; Zuckerman M; Babaahmady K; Schuitemaker H; Shaunak S; Rostron T; Rowland-Jones S; Simmons G; Clapham P
    AIDS; 2001 Sep; 15(13):1613-26. PubMed ID: 11546935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of HIV infection by CXCR4 and CCR5 chemokine receptor antagonists.
    De Clercq E; Schols D
    Antivir Chem Chemother; 2001; 12 Suppl 1():19-31. PubMed ID: 11594685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytolysis by CCR5-using human immunodeficiency virus type 1 envelope glycoproteins is dependent on membrane fusion and can be inhibited by high levels of CD4 expression.
    LaBonte JA; Madani N; Sodroski J
    J Virol; 2003 Jun; 77(12):6645-59. PubMed ID: 12767984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Levels of Macrophage Inflammatory Proteins Result in Resistance to R5-Tropic HIV-1 in a Subset of Elite Controllers.
    Walker WE; Kurscheid S; Joshi S; Lopez CA; Goh G; Choi M; Barakat L; Francis J; Fisher A; Kozal M; Zapata H; Shaw A; Lifton R; Sutton RE; Fikrig E
    J Virol; 2015 May; 89(10):5502-14. PubMed ID: 25740989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage-tropic HIV induces and exploits dendritic cell chemotaxis.
    Lin CL; Sewell AK; Gao GF; Whelan KT; Phillips RE; Austyn JM
    J Exp Med; 2000 Aug; 192(4):587-94. PubMed ID: 10952729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lineage-specific expression of human immunodeficiency virus (HIV) receptor/coreceptors in differentiating hematopoietic precursors: correlation with susceptibility to T- and M-tropic HIV and chemokine-mediated HIV resistance.
    Chelucci C; Casella I; Federico M; Testa U; Macioce G; Pelosi E; Guerriero R; Mariani G; Giampaolo A; Hassan HJ; Peschle C
    Blood; 1999 Sep; 94(5):1590-600. PubMed ID: 10477684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased replication of T-cell-tropic HIV strains and CXC-chemokine receptor-4 induction in T cells treated with macrophage inflammatory protein (MIP)-1alpha, MIP-1beta and RANTES beta-chemokines.
    Dolei A; Biolchini A; Serra C; Curreli S; Gomes E; Dianzani F
    AIDS; 1998 Jan; 12(2):183-90. PubMed ID: 9468367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.